The Courts and Congress Take Aim at Patent False Marking Lawsuits

          This week, the Court of Appeals for the Federal Circuit ruled that a complaint for false patent marking must provide specific facts from which the court can reasonably infer an intent to deceive the public, thus raising the bar to initiating such a suit. A conclusory statement that the defendant knew or should have known that a patent has expired is insufficient to meet this pleading requirement.  As discussed below, this holding, along with previous court decisions, will likely significantly curtail the number of false patent marking suits filed.  And if proposed legislative amendments to the false marking statute recently passed by the U.S. Senate become law, false marking lawsuits may become a thing of the past.

          In 2007, Matthew Pequignot, a patent attorney, filed a lawsuit in the U.S. District Court for the Eastern District of Virginia against the Solo Cup Company seeking a monetary penalty available under the Patent Act’s “false marking” statute, 35 U.S.C. § 292. At the time, few probably predicted that by 2011 nearly a thousand such lawsuits would be filed, including some against well known companies like Proctor & Gamble, Gillette, Brooks Brothers, and Crayola. Section 292 states that:

“(a) Whoever marks upon, or affixes to, or uses in advertising in connection with any unpatented article, the word “patent” or any word or number importing that the same is patented for the purpose of deceiving the public . . . [s]hall be fined not more than $500 for every such offense.

(b) Any person may sue for the penalty, in which event one-half shall go to the person suing and the other to the use of the United States.”

          Section 292 is a qui tam action, which is an action whereby a private individual or company sues on behalf of the U.S. government and himself, and in return gets a share of any penalty imposed by a court. Section 292 is one of four federal qui tam statues. See Vermont Agency of Natural Resources v. United States ex rel. Stevens, 529 U.S. 765 (2000). Section 292 is a criminal statute, but with a civil (i.e., monetary) penalty. See 16 James Wm. Moore et al., Moore's Federal Practice—Civil § 107(B)(2).

          In 2010, the Federal Circuit issued its decision in an appeal brought in Mr. Pequignot’s 2007 lawsuit. In its published opinion, Pequignot v. Solo Cup Co., 608 F.3d 1356 (Fed. Cir. 2010), the Federal Circuit affirmed the lower court’s judgment of no liability in favor of Solo Cup, and in doing so made several key findings about the false marking statute and its application. The Court stated unequivocally that “any article marked with an expired patent number is falsely marked” under the statute, and every falsely marked product  (“unpatented article”) constitutes a separate “offense” under 292. Id. at 1362, 65. (That later finding is what has encouraged many false marking lawsuits, since a million falsely marked articles could mean a penalty fine of up to $500 million, half of which would go to the plaintiff.) With regard to the “purpose of deceiving” language in the statute, the Court said that any false statement with knowledge that the statement was false creates a “rebuttable presumption of intent to deceive the public.” Id. at 1462-63. But, the Court also said, because § 292 is in effect a criminal statute, the “bar for proving deceptive intent [ ] is particularly high.” Id. For example, the mere knowledge that a marking is false is insufficient to prove intent, especially where the defendant “can prove that it did not consciously desire the result that the public be deceived.” Id. The defendant also has an evidentiary burden, and must produce adequate proof to rebut the presumption that it intended to deceive the public. The “mere assertion by a party that it did not intend to deceive” is insufficient to overcome the presumption of intent. Id. Considering the evidence offered by both parties, the Court found in favor of Solo Cup on its motion for summary judgment partly because, while Solo Cup had knowledge that some of its products were falsely marked, it produced evidence that it had obtained and relied upon an opinion from its counsel and took other actions consistent with its argument that it did not intend to deceive the public.

          Earlier this week, in In re BP Lubricants USA, Inc., ___ F.3d ___ (Fed. Cir. March 15, 2011), upon a petition for writ of mandamus filed by BP Lubricants in another qui tam action brought under § 292, the Federal Circuit held that the particularity requirement under Fed. R. Civ. P. 9(b) “applies to false marking claims” under § 292, which was a question of first impression for the Court. At issue was plaintiff’s complaint, filed in the U.S. District Court for the Northern District of Illinois in early 2010, which alleged “mostly ‘upon information and belief,’ that: (1) BP knew or should have known that the patent expired; (2) BP is a sophisticated company and has experience applying for, obtaining, and litigating patents; and (3) BP marked the CASTROL products with the patent numbers for the purpose of deceiving the public and its competitors into believing that something contained or embodied in the products is covered or protected by the expired patent.” Applying Rule 9(b)’s requirement that fraud or mistake must be plead with particularity, the Court found that the relator’s (plaintiff's) complaint “provided only generalized allegations rather than specific underlying facts from which we can reasonably infer the requisite intent, [therefore] the complaint failed to meet the requirements of Rule 9(b).” The Court dismissed plaintiff’s argument that false marking inherently shows scienter, and that identifying individuals who had knowledge of expired patents was practically impossible at the pleading stage. The Court agreed with the plaintiff that “the Pequignot presumption informs the determination of whether a false marking plaintiff has met Rule 9(b),” but, the Court said, that is but “one factor in determining whether Rule 9(b) is satisfied; it does not, standing alone, satisfy Rule 9(b)’s particularity requirement.” The Court granted BP the “extraordinary remedy of mandamus.”

          Companies that sell products marked with their patent numbers should find comfort in the fact that the Federal Circuit has made it more difficult for plaintiffs to bring false marking qui tam actions because of the burden to plead, with particularity, the underlying facts needed to establish scienter under § 292, and because of the difficulty in winning such lawsuits once they are filed because the presumption that a company intended to deceive the public can be rebutted. And if patent reform legislation passed in the Senate becomes law, companies will have even more to celebrate because the newly shaped false marking statute, as discussed below, would effectively put the brakes on the rush to file false marking lawsuits.

          Under Sec. 2(k) of the “America Invents Act” (S.23; formerly the “Patent Reform Act of 2011”), which passed the U.S. Senate on March 8 by a wide margin (95-5 in favor of passage), § 292(a) of the statute would be amended by adding at the end: “Only the United States may sue for the penalty authorized by this subsection.” The bill would also replace § 292(b) of the statute in its entirety with the following new provision: ‘‘(b) Any person who has suffered a competitive injury as a result of a violation of this section may file a civil action in a district court of the United States for recovery of damages adequate to compensate for the injury.’’ Obviously, non practicing entities, like many of the plaintiffs who brought false marking lawsuits recently, would not likely suffer any “competitive injury” as a result of another’s falsely marked products unless they too were making and selling products in the same market segment. And even if they were making and selling such products, only an “adequate” recovery may be awarded to the plaintiff under the new law, not the $500 per falsely marked product as provided in the present statute. (Notably, under the new law, the government would bring suit under §292(a), and the private right of action is only in civil court under §292(b), which may address concerns expressed by at least one District Court that the current law is unconstitutional. See Unique Pro. Solutions Ltd. v. Hy-Grade Valve Inc., slip op. No. 5:10-01912 (N.D. Ohio Feb. 23, 2011) (holding that the qui tam provision of the false marking statute, 35 U.S.C. §292(b), is unconstitutional under the Take Care Clause of the United States Constitution, U.S. Const. Art. II, §3).)

          At the time of this article, the U.S. House of Representatives has not taken up S.23. And if it does, there is no assurance Sec. 2(k) will survive the cut. But if the legislation passes without significant alteration, the threat of qui tam actions brought under § 292 could become much less of a concern to businesses.

Federal Circuit Clarifies Waiver of Attorney-Client Privilege and Work Product Immunity in Patent Litigation

Summary: The Federal Circuit clarifies the scope of the waiver of attorney-client privilege and work product protection that results when an accused patent infringer asserts an advice of counsel defense to a charge of willful infringement. Case:  In Re Seagate Technology, LLC, Civ. No. 830 (Fed. Cir. 2007) (en banc) (Newman, J., Garjarsa, J., concurring).


     Convolve, Inc., and MIT (“Convolve”) sued Seagate, alleging willful infringement of U.S. Patent Nos. 4,916,635, 5,638,267, and  6,314,473. Prior to the lawsuit, Seagate had obtained from outside counsel three opinion letters covering infringement, validity, and enforceability of those patents. Seagate notified Convolve of its intent to rely upon the three opinions in defending itself against willful infringement.  It then disclosed its outside counsel’s work product and made him available for deposition. Convolve then moved to compel discovery of any communications and work product of Seagate’s other counsel, including its trial counsel. The S.D.N.Y. sided with Convolve, concluding that Seagate waived the attorney-client privilege for all communications between it and any counsel, including opinion, trial, and in-house counsel, concerning the subject matter of the opinion letters. 

     In response, Seagate filed a petition for writ of mandamus with the Federal Circuit, which was granted. After ordering en banc review, the Federal Circuit ordered the S.D.N.Y. to reconsider its order compelling discovery.  In doing so, the Federal Circuit overruled its earlier decision in Underwater Devices Inc. v. Morrison-Knudsen Co., 717 F.2d 1380 (1983), and clarified the scope of the waiver of attorney-client privilege and work product protection that results when an accused patent infringer asserts an advice of counsel defense to a charge of willful infringement. The court’s opinion addressed three significant issues: the standard for awarding enhanced damages, the scope of the waiver of trial counsel-client privileged communications, and the scope of the waiver of trial counsel’s work product.

Standard for Awarding Enhanced Damages in Patent Cases

     The Federal Circuit concluded that the duty of care it announced in Underwater Devices was akin to negligence, which was a lower threshold compared to other comparable civil statutory frameworks. Such a low standard, the court said, “does not comport with the general understanding of willfulness in the civil context…, and it allows for punitive damages in a manner inconsistent with Supreme Court precedent.”  Accordingly, the court overruled the Underwater Devices standard and held that proof of willful infringement permitting enhanced damages requires at least a showing of objective recklessness, a higher standard than negligence. “Because we abandon the affirmative duty of due care,” the court wrote, “we also reemphasize that there is no affirmative obligation to obtain opinion of counsel.”

Scope of Attorney-Client Waiver

     Noting that district courts have reached varying results with respect to whether communications with trial counsel are waived when a client relies upon opinion of counsel as a defense to a charge of willfulness, the Federal Circuit said:

“[W]e conclude that the significantly different functions of trial counsel and opinion counsel advise against extending waiver to trial counsel. Whereas opinion counsel serves to provide an objective assessment for making informed business decisions, trial counsel focuses on litigation strategy and evaluates the most successful manner of presenting a case to a judicial decision maker. And trial counsel is engaged in an adversarial process. * * * Because of the fundamental difference between these types of legal advice, this situation does not present the classic “sword and shield” concerns typically mandating broad subject matter waiver. Therefore, fairness counsels against disclosing trial counsel’s communications on an entire subject matter in response to an accused infringer’s reliance on opinion counsel’s opinion to refute a willfulness allegation. “

     The court supported its position with several additional reasons, but it also noted that in reaching its decision, “[w]e do not purport to set out an absolute rule.”  Trial courts should continue, the court said, to exercise their discretion in unique circumstances to extend waiver to trial counsel, such as if a party or counsel engages in “chicanery” (def'n: trick, trickery, subterfuge).

Scope of Work Product Waiver

     Relying upon the same rationale limiting waiver of the attorney-client privilege with regard to trial counsel, the Federal Circuit concluded that a party relying upon opinion counsel’s work product does not waive work product immunity with respect to trial counsel.   This general limitation is necessary because of the nature of the work product doctrine, the court said, and because protecting lawyers from broad subject matter disclosure “strengthens the adversary process, and . . . may ultimately and ideally further the search for the truth.” However, the Federal Circuit also stated “we leave open the possibility that situations may arise in which waiver may be extended to trial counsel, such as if a patentee or his counsel engages in chicanery.”

Held: Seagate’s petition for a writ of mandamus was granted; the district court was ordered to reconsider its discovery orders in light of the Seagate opinion.

Comments:

  • This case may strengthen the long held belief by patent attorneys that patent litigation trial counsel should be different than opinion counsel. See William L. LaFuze, Matthew R. Rodgers & Michael A. Valek, Exculpatory Patent Opinions and Special Problems Regarding Waiver of Privilege, 6 J. MARSHALL REV. INTELL. PROP. L. 313 (2007) (available here)

  • In the Seagate opinion, the Federal Circuit noted that a willfulness claim asserted in the original complaint must necessarily be grounded exclusively in the accused infringer’s pre-filing conduct. By contrast, when an accused infringer’s post-filing conduct is reckless, a patentee can move for a preliminary injunction, which generally provides an adequate remedy for combating post-filing willful infringement. A patentee who does not attempt to stop an accused infringer’s activities in this manner should not be allowed to accrue enhanced damages based solely on the infringer’s post-filing conduct. Similarly, if a patentee attempts to secure injunctive relief but fails, it is likely the infringement did not rise to the level of recklessness.   What does this say about the use of injunctions in patent cases in the future?

Bifurcated Patent Trials, Expected Delays, and Press Statements

          Petersburg, Virginia-based Star Scientific, whose published corporate mission is to “reduce toxins in tobacco so that adult consumers can have access to products that expose them to sharply reduced toxin levels,” sued R.J. Reynolds for patent infringement in the District Court for the District of Maryland in 2001. A bench trial on the issue of the enforceability of the asserted patents was held in 2005. Apparently put off by what it viewed as an excess delay in receiving the District Court’s decision, Star petitioned the Court of Appeals for the Federal Circuit (CAFC) seeking a writ of mandamus from the court that would order the Maryland District Court to issue its decision regarding unenforceability within 30 days. Star's petition was filed before June 7, 2007, which is the date the Maryland District Court issued an order stating that its decision would be posted on June 29, 2007.   Defendants/respondents R.J. Reynolds Tobacco Company (a North Carolina corporation) and R.J. Reynolds Tobacco Company (a New Jersey corporation) opposed Star’s petition. 

          In an Order signed June 25, 2007, Federal Circuit Court Judge Pauline Newman denied Star’s petition, stating that the company had not “met its burden in this case,” which, for a writ of mandamus, required Star to establish that there had been a “clear abuse of discretion or that the District Court has ‘obstinately refuse[d]’ to adjudicate the matter” (citing Will v. Calvert Fire Ins. Co., 437 U.S. 655, 666-67 (1978)). 

          Ironically, the same day the Federal Circuit issued its Order denying Star’s petition, the Maryland District Court issued its decision on enforceability, effectively mooting Star’s petition to the CAFC. The District Court found Star’s patents to be unenforceable on the basis of inequitable conduct by Star’s attorneys during prosecution of Star’s patents before the U.S. Patent & Trademark Office. Star responded forcefully to the decision.  In a June 27, 2007, press statement, it stated:

“The company is disappointed and frankly outraged by the U.S. District Court's ruling yesterday…. The Court's conclusion that highly respected and experienced senior attorneys at four national law firms were involved in an alleged plot to deceive the Patent Office is stunning and totally without support in the record. The opinion ignores significant portions of the record, distorts others, and spins a tale that is unrecognizable to those who attended the trial. … We welcome the opportunity to present the record in this case to objective decision-makers on the Federal Circuit.”

Comments and Notes:

  • Star’s frustration over a two-year delay in receiving a decision regarding enforceability of its patents is understandable.  However, bifurcated trials nearly always take longer to reach finality.

  • It remains to be seen what effect Star’s press statement will have on its case-in-chief if the Federal Circuit remands the case back to the same Judge whose decision, in Star's view, ignored portions of the record, distorted portion of the record, and spun an unrecognizable tale.

  • This case underscores one of the many pre-filing decisions Plaintiffs must evaluate before bringing a lawsuit:  the speed with which a court adjudicates patent matters.